Fluvoxamine is a cheap, generic, oral drug that is classified and used as an antidepressant. That said, recent trials have tested its use as early, at-home treatment for COVID-19 and so far, the results look extremely promising. So promising that an application was recently submitted to the FDA for emergency use authorization as early treatment for COVID-19.
In this episode of Causes or Cures, Dr. Eeks chats with Dr. Eric Lenze, a psychiatrist and clinical trialist at Washington University in St. Louis, who ran one of the randomized controlled trials on fluvoxamine. His study was published here in JAMA. In this episode, he will discuss what fluvoxamine is, why he and his team decided to study its use against COVID-19, results of the trial and subsequent trials, dosing issues, side effects, concerns about withdrawal and how the drug can help bring an end to the pandemic.
To contact Dr. Eeks, do so through bloomingwellness.com
Or follow her on Instagram here.
Or Facebook here.
Subcribe to her newsletter here!